Pemphigus and bullous pemphigoid are autoimmune bullous diseases of the skin. Pemphigus, an intraepidermal blistering disease, is characterized by autoantibodies reactive with antigens located in the intercellular spaces or on the surfaces of epidermal cells. These antibodies, which have recently been shown to activate complement, appear to be the cause of the basic pathologic process of pemphigus, acantholysis. The complement system and the plasminogen-plasmin system may be important mediators in the detachment of epidermal cells. Bullous pemphigoid, a subepidermal blistering disease, is characterized by autoantibodies reactive with an antigen located in the lamina Iucida region of the basement membrane zone. These autoantibodies, which will avidly fix complement, appear to mediate subepidermal separation by attraction of a variety of inflammatory cells. Anaphylatoxins, released by activation of C4 and C3, or specific lgE antibodies, may activate mast cells with release of ECF-A attracting eosinophils. With activation of C5, C5a is released which could attract polymorphonuclear leukocytes. Antigen-specific lymphocytes, which can also contribute histamine releasing substances, may also be involved. The exact mechanism by which the epidermis separates from the dermis in bullous pemphigoid, however, remains unresolved.
in pemphigus has received considerable investigative attention in recent years.
Bullous pemphigoid, on the other hand, is a bullous disorder which affects mainly middle-aged and older persons [2] . Like pemphigus, bullous pemphigoid is a member of a group of diseases which share similar histopathologic and immunopathologic findings. Other members of this disease group include cicatricial pemphigoid, localized scarring pemphigoid (Brunsting-Perry type), and herpes gestationis. Lesions of bullous pemphigoid may appear as grouped bullae of vesicles arising in greatest numbers in flexural areas (groin, axillae, anticubetal fossae, etc.) usually healing without scarring. Remissions and exacerbations usually occur during a 6-10 year course of the disease, and spontaneous complete resolution is customary. Histopathologically, bullous pemphigoid is a subepiderma l blistering skin disease.
\

PEMPHIGUS
Pemphigus is an autoimmune disease of the skin . By direct immunofluorescence (IF) staining, numerous studies have confirmed the presence of serum autoantibodies with reactivity for antigens localized to t he intercellular substance (ICS) of epidermis or the surfaces of individual epidermal cells [1 -4] . These autoantibodies are of the IgG type, reside in all subclasses of lgG [5] , and are present in all types of pemphigus, an additional feature which unifies members of this disease group. Levels of pemphigus ant ibodies often fluctuate with activity of disease, being high during periods of disease activity and low or entirely absent during periods of remission [6, 7] .
In recent years, co nsiderable investigative effort has been focused upon the antigens reactive with pemphigus antibodies. To review a ll suc h attempts published thus far would be beyond the scope of this review. Suffice it to say, some controversy still exists concerning the size of t he antigen or antigens. Diaz and co -workers [8] isolated a glycoprotein from human saliva (presumably produced by oral mucosa cells) with a molecular weight of approximately 50,000 daltons, while Stanley et al [9] have identified a 210,000 dalton protein which when reduced has 130,000 and 80,000 molecular weight chai ns. Stanley and coworkers [10] have also recently shown some but not alf pemphigus foliaceus sera are reactive with ant ige ns which differ from those associated with pemphigus vulgaris . Whatever t heir composition, t hese antigens are clearly produced by and expressed on the surfaces of epidermal cells [ 4, 11] and appear to be important in cell -cell adhesion [12] .
Several lines of evidence suggest that antibodies found in the sera of patients with pemphigus are the cause of the disease process. By direct IF methods, early acantholytic areas of pemphigus skin and oral lesions have heavy ICS deposits of lgG [1 3,14] . Thus, pemphigus antibodies, in addition to their presence in serum, are capable of leaving the circulation and reacting with epidermal cell surface antigens in vivo. In addit ion to finding IgG deposits in these skin lesio ns, a variety of complement components, including C1q, C4, C3 (Fig lA) , B and properdin have also been identified in these ICS deposits [15] [16] [17] .
The first convincing evidence that the antibodies found in sera of pemphigus patients are responsible for acantholysis was presented several years ago by Michel, Schiltz, and co-workers 72s
July 1985
IMMUNOPATHOLOGIC MEC HANI S MS IN PEMPHIGU S AND BULLO US P E MPHIGOID 73s [18, 19] . Wi t h expla nts of normal hu_ man s~in i!1 t he p r~se n ce of pemphigus lgG in organ cul t ure, htstologtc evtdence of acant holysis occurred wi t hin 48-72 h. Late r, Fa rb , Singe r, a nd coworkers (20,2 1] demonstrated t hat epiderma l cell detachment occurs when pemphigu s lgG was added to monolayers of epiderma l cells in cul ture. They fur t her showed t hat pemphigus IgG would stimul ate t he release of proteinases in t h~ir cul t ure systems, studies confirmed by Woo eta! [22 ] . H ashtmoto a nd co-workers [23 ) recen t ly ident ified t he proteinase released by cul tured epiderma l cells when t reated wi t h pemphigus lgG as plasminoge n activato r (PA) . They have proposed t hat activatio n of plas minoge n to plasmin by P A may be responsible for acant holysis. T o su bstan t iate t hi s hypothes is fur t her, Morioka, J ensen, and Lazarus [24 ] have recent ly s hown t hat t he addi t ion of plasmin to t he epiderm al cul t ure systems will resul t in epiderma l ce ll detac hm ent.
As t he above investigat ions were a ll performed in t he abse nce of complement [1 [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] 23] , the involvement of t he co mplement system in t he process of aca nt holys is has remained cont roversial. Despite t he fact t hat complement deposits a re present in pemphi gus lesions by direct IF [1 5-17], ea rl y attempts to demonstrate t hat pemphigus a ntibodi es would fix co mpl emen t fa iled [25 ] . Lat er, Nishikawa et a! [26 ) a nd Hashimoto et a! [27) we re ab le to demonstrate by in vit ro co mplemen t IF stainin g t hat some pemphigus a ntibodies would fi x complement to norma l huma n skin. We have rece ntly co nfirmed t heir studies and exte nded t hem by show ing that pemphigus an t ibodies will fi x complement to orga n cul ture skin explants and to epiderm al monolaye rs ( Fig 1B) in t issue cul t ure [11] . As t hese a ntibodies would fix the early co mponents Clq and C4, and in addi t ion C3 (Table I) , pemp higus ant ibodies appear to fix co mplement via t he classical pathway.
The next question we wished to address was whether co mplement might enha nce pemp higus IgG induced detachmen t of epiderma l ce ll s in cul ture. Thus, we chose to ut ilize a system as desc ri bed by Woo a nd co-workers [22] , but choosing a pemphi gus IgG co ncent ration (1 mg/ ml ) reported by t hem to be in sufficient to cause detachment of monolaye rs of cul t ured epidermal cells. T hus, in our system, minimal cell detac hment occurred when 1 mg/ml pemphigus was added to t he 48-h cul tures a lone. When co mplement was added lo such cultures studi es in pemphi gus. (a) Direct IF staining of a n ea rly aca nt holytic pemphigus skin lesion usin g labeled a nti human C3 a nt ise rum . Intercellula r substance sta ining is evident. x 400 (o ri gina l magnifi catio n). (b) Mouse epi de rma l monolaye r in cubated wit h 3 mg/ ml pemphigus lgG. Foll owing in cubation with com plement, t he cell s were t reated wit h labeled a nt ihuma n C3 . Positive speck led staining on t he ce ll sur faces is ev ident . x 625 (o ri gin a l magnificatio n). • C: 10% ABnormal huma n se rum was used as t he source of co mplement.
TA B L E I. In vitro complemen t staining reactions with mouse epidermal monola.yers and organ cultured normal human skin "
·· -to +++: In tensity of sta ining. Spec kled patte rn in epiderm al monolaye rs or ICS staining in organ cul tured skin. Resul ts obta ined usin g epiderm al monolaye rs or orga n cul t ure skm were tdent tcal.
(T able II) , significa nt detac hment of cult ured epiderm a l cells became apparent [28] . By using C1q depleted serum of _ heat inactivated serum as t he complement source (T able II), eptdermal cell detachmen t was completely inh ibited. Depletion of plasminogen from both t he pemphigus l gG fractions and t he complement source on the other hand failed to inhibi t cell detac hmen t*. Thus, complement activation by pemphigus ant ibodies prov ides an addit ional mechanism for loss of epiderma l cell cohesion in addi t ion to t he plasminogen-plasmin system.
Passive transfer studies also suggest t hat pemphigus antibodies a re pathogenetic. Buschard et a! [29] developed a model in athymic mice using expla nted oral mucosa. One week fo llowin g expla ntation, res a nt ibodies were injected int raperi to neall y.
Binding of ICS ant ibodjes could be detected and histologic evidence of aca ntholysis could be seen in t he sites of t he oral mucosa l expla nts. M ore recently, da ily i.p. injections of pemph igus se rum into 24 h old mice by Anhalt et al [30) in bliste ring sk in lesions at about 1 week. These , · in lesions were hi stologica ll y identi cal to true pemph igus lesions a nd with binding of ICS antibodies to t he mouse skin. These studies have recently been co nfirm ed and exte nded by Peterson and Wuepper [31] who, in addition to passively transferring t he disease in neonatal mice, used a rabbit antiserum to purified pemphigus antigen to induce the experimental lesions. Thus, the disease pemphigus has been successfully passively transferred to ex perimental a nima ls.
Mechanistically, then acantholysis in pemphigus appears to result from t he interaction of pemphigus antibodies with epidermal cell surface antige ns t hought to be important in cellcell adhes ion. Both activated complement and plasmin appear to mediate t he ce ll detachment associated with th is disease process (Fig 2) . The role ce ll s play, such as eosinophils, which are commonly found in early infiltrates, remains to be determined.
BULLOUS PEMPHIGOID
Like pem phigus, bullous pemphigo id is also an autoimmune bullous s kin disease. This subepidermal blistering disease, however, is characteri zed by circulatin g lgG autoantibodies which react wi t h a nt ige ns located in t he la mina Iucida region of the basement membrane zo ne (BMZ) [1, 32, 33] . The a ntigen(s) reactive with t hese ant ibodies, which have been part ially characteri zed [34, 35] , appear to be produced by basal keratinocytes [4] and deposited along the BMZ [36] .
By histopathology, a va riety of infl ammato ry ce lls have been identified in bullous pemphigoid infiltrates. Non inf1ammatory appearin g lesions show a sparse perivascul a r infiltrate of eosinophils a nd mononuclear cells. By contrast, inflammatory lesions show a dense perivascular and subepidermal infiltrate consistin g predominantly of eosinophils with mononuclear cells and polymorphonuclea r leukocytes (PMNL) present in smaller numbers. Low eosinophil a nd high eosinophil lesions [37, 38] 1 ' -to +++: The extent of cell detachment visualized by phase microscopy.
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have been noted by several investigators; close light microscopic and electron microscopic studies of very early lesions reveal prominent mast cells in the reticular and papillary dermis showing focal irregular loss of granules as well as degranulation, karyorhexis, and karyolysis of eosinophils [39, 40] . Tissue injury which precedes frank dermal-epidermal separation is also prese nt in early lesions [41] . Basal keratinocytes show loss of hemidesmosomes, and widening of intercellular spaces. Vascular injury is apparent with endothelial hypertrophy, focal luminal obliteration, and focal endothelial cell death [39] .
The earliest clues to t he pathogenic mechanisms which might be responsible for the t issue injury outlined above came from IF and immunoelectron microscopic (IEM) studies. In vivo bound gamma globu lin was noted at the BMZ in lesions of bullous pemphigoid [32] . Later, classes of immunoglobulins were defined and evidence of complement activation [ 42] was noted. Most commonly, IgG and/or C3 are found at the BMZ (Fig 3) . IgA and lgM are found in about 25 % of the cases [38, 43] . In addition, IgE has been noted at the BMZ (44] and on mast cell surfaces in involved skin of bullous pemphigoid patients [45 ] . Evidence for classical complement pathway act ivation [ 46,4 7] as well as a lternate pathway activation has been established (48) (49) (50) . {3 1 H globu lin , a cofactor for C3biNA, has also been detected using IF studies in involved skin [51] [52] [53] . More recently, Dahl and associates [54] have demonstrated deposition of t he membrane attack complex (C5-9) in bullous pemphigoid lesions (Table III) .
IEM of lesional sk in has localized the immunoglobulin deposition to the sub-basalar lam ina Iucida area [33] . Others have furt her noted C3 in this location [55] , as well as "lumpy-bumpy" immunoglobulin deposition sub-basally and intercellularly suggesting immune complex deposition [56] . Immune complexes have a lso been noted in some BP patients with active disease, but negative indirect IF [57] . This suggests that bullous pemphigoid antigen may be produced in excess and may even circulate, thus providing a nidus for immune complex formation. Immune complexes have also been detected in bullous pemphigoid blister f1uids [58] .
The IF studies of lesional tissue provide evidence that t he humoral aspect of the immune system plays a role in lesion formation , with a cellular component as well. This latter evidence, however, is more difficult to interpret.
The mast cell cou ld be viewed as a bridge linking t he cellular and humoral components in lesion development. It is observed to be present and to have a degranulated appearance in early lesional tissue [59] . Under the influence of an appropriate stimu lus such as IgE, C3a or C4a [60] , the mast cell will release histamine, slow reacting substance of anaphylaxis (SRS-A), eosinoph ilic chemotactic factor of a naphylaxis (ECF-A), high molecular weight neutrophil chemotactic factor (HMW-NCF) platelet-activating factors, and enzymes. C4a and C3a are derived following the activation of C4 and C3 [61] . As many 
/31H globulin Properdin b ullous pemphigoid antibod ies have been shown to activate complement in vivo and in vi tro, one could postulate t hat complement activation, rather t han causin g direct t issue injury, triggers mast cell degranulation with histam ine release resulting in "leakiness" of blood vessels a nd chemoattraction of eosinophils, (ECF-A) and PMNL (HMW-NCF). C4a, C3a a nd C5a produced by complement activat ion could further amplify the chemoattractive effect [62, 63 ] . Examination of blister fluid helps to substantiate t his theory of pathogenesis. Complemen t activation leading to a decreased CH 50 of blister fluid as compared to serum CH50 in t he same patient has been observed [64] . Immune co mplexes which form a nd have been detected in t hese blister fluids [58] might contribute to t hese depressed blister fluid CH50 levels. This reduced CH 50 is associated with increased chemotactic activity of blister fluid [65 ] . A number of immune modulating factors have also been observed in bullous pemphigoid blister f1uid, including ECF-A [66, 67 ] , eosinop hil co lony stimulati ng material or ESM [68] , lymphocyte chemotactic material [69] , and prostaglandin E 2 [70) . Enzymatic activity in blister fluid has also bee n noted [71] . These findings can be in terp reted as evidence for humora l and cellular activity in t he bullous pemphigoid les ion.
The difficulty lies in determ ining a causa l relationship bet wee n cellular and humora l aspects and in proving which if any actually produces the histologic change of dermal epidermal separation. Dubertret et a! [72 ) using histologic studies propose F IG 3. IF studies in bullous pemphigo id. (a) Direct IF stain ing of ski n adjacent to a lesion of bullous pemphigoid usin g labe led a nti human C3. Stai ni ng of t he basement membrane zone is ev ident. x 250 (origin al magn ifi cation) . (b) In vitro co mplement IF sta ining of normal human skin using serum from a patient with bullous pemphigoid and labeled a nt ihuma n C4. Staining of the basement membrane zone is evident. x 250 (original magnification).
that direct keratinocytic killing and enzyme release by eosinophils leads to blister formation. T he eosinophil , abundant in most inf1ammatory lesions of bullous pemphigoid is capable of antibody dependent cellular cytotoxicity (ADCC) k illing of a variety of cell types in cult ure [73] . An associated eosinophilia is often noted in cases of bullous pemphigoid [74] .
Attempts to develop an in vitro model have foc used on the role of complement a nd PMNL in lesion formation. Anhalt et a! have produced microblebbing and a PMNL rich inflammatory infilt rate by injecting bullous pemphigoid antibody into rabbit cornea [75] . Gammon et a!, using an in vitro model of t he dermal-epiderma l junction, have demonstrated directed migration of PMNL to t he BMZ in t he presence of bullous pemphigoid an tibody and complement [76] . Although activation of PMNL has been demonstrated [77] , no true separation of epidermis from dermis has been demonstrated in vitro using bullous pemphigoid ant ibody and complement [78] or PMNL [76, 79, 80] . It appears then t hat some other cell(s) or factor(s) may be necessary for fulllesional development. Indeed, t he role of t he PMNL may be to elaborate ECF-A after ingestion of immune complexes [58, 67] . However, other possible roles for the PMNL could be elaboration of lytic enzymes or direct keratinocyte killing or injury via ADCC.
The mononuclear cell is also present in inflammatory infiltrates of bullous pemphigoid. The role of t he lymphocyte and/ or monocyte macrophage in bullous pemphigoid is poorly understood. As noted above, a lymphocyte chemotactic factor has been isolated from blister bluid [69] . The source of t his facto r is unknown , alt hough peripheral blood mononuclear (Ficoll Hypaque separated cells) will elaborate a factor chemotactic for lymphocytes when stimulated with mitogen in vitro [81) .
It has also been noted t hat PPD-specific lymphocytes will acc umulate within and beneath artificial blisters overlying dermal injections of PPD in vivo [82 ] . Thus, lymphocytes may accumulate in response to specific a nt igen and/or chemoattractants elaborated by stimulated monocytes or other mononuclear cells. The role of t he lymphocyte is also unclear si nce these cells are capable of a number of varied activities . One possible role for t he lymphocyte is as a source of histam ine releasing facto rs [83 ) . This would permit long-term stimulation of mast cells to e labo rate chemoattractants a nd histamine thus pe rpetuating t he immune respo nse locally. Another possible role would be direct cytotox ic e ffect o n basal ke rati n ocytes. These functio ns re m a in to be experime n ta lly tested in vit ro using a model that is capable of fulllesional expression, t h at is, dermalepiderma l separatio n , s uc h as o rga n cu lt ure or ep ide rma l m o no layers o n dermal-epidermal junctio n -like glycoprote in m atrix. Based o n t he ev ide nce presen ted, we propose t he following mechanis m of tissue injury in bullous pemphigoid: Bullous pemphigoid antige n in some way rendered immunoge nic to stimulate an a n t iself clon e of B cell /plasma cell s. Va rious classes of a n tibu llous pemphigoid antigen antibodies are e laborated w it h l gG predo min atin g. The s pecific l gG binds bullous pemph igoid a n t ige n in its normal lami n a Iucida locatio n a nd begins fixing a nd activating compleme n t (Fig 4) . Among othe r thi n gs, C3a a nd C4a are e laborated. M ast cells degranulate e laborati n g ECF -A, HMW -NCF, perhaps ESM, histam ine, a nd e nzymes. Eosinoph il s a nd PMNLs a re recruited and possibly bind vi a C3b receptors to t he dermal-epide rm a l junction. By direct cytotox ic actio n o r because of e n zy m es e laborated, a rupture of t he dermal-epidermal attac hm e nt is produced a nd a bliste r formed . Lymphocytes in t he a rea e laborate HRF (histam ine re leasing fa cto r) to up regulate mast cell degranu latio n a nd t he lesio n s progressed to s how bullae, o fte n in groups extending over weeks a nd m o nt hs. This proposed model would account for most of the findin gs to date in bullo us p e mphigoid a nd the tas k now is to iso late a nd seque n ce t h e discrete events leadin g to clinical expressio n of t h e di sease.
